Clinical Trial Update: Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

View source ↗

Summary

A clinical trial is evaluating whether D-dimer and C-reactive protein can predict cardiovascular risk in patients with end-stage renal disease on dialysis, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Assiut University | Conditions: End Stage Renal Disease on Dialysis | Status: NOT_YET_RECRUITING